PROTRIEVE Trademark

Trademark Overview


On Monday, February 23, 2015, a trademark application was filed for PROTRIEVE with the United States Patent and Trademark Office. The USPTO has given the PROTRIEVE trademark a serial number of 86543084. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 19, 2018. This trademark is owned by Actavis, Inc. The PROTRIEVE trademark is filed in the Pharmaceutical Products category with the following description:

Oral, transdermal, injectable and intravaginal contraceptive preparations, intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medic...
protrieve

General Information


Serial Number86543084
Word MarkPROTRIEVE
Filing DateMonday, February 23, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 19, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 18, 2015

Trademark Statements


Goods and ServicesOral, transdermal, injectable and intravaginal contraceptive preparations, intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antimicrobial preparations for inhibiting microbiological decomposition in pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, Central Nervous System disease and disorders, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent for medical purposes; antidepressants; antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
Translation of Words in MarkThe wording "PROTRIEVE" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 9, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameALLERGAN FINANCE, LLC
Party Type22 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressMadison, NJ 07940

Party NameAllergan Finance, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054

Party NameActavis, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Party NameActavis, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Monday, November 19, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 19, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 16, 2018EXTENSION 5 GRANTED
Thursday, April 12, 2018EXTENSION 5 FILED
Thursday, April 12, 2018TEAS EXTENSION RECEIVED
Wednesday, January 3, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, October 5, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 3, 2017EXTENSION 4 GRANTED
Tuesday, October 3, 2017EXTENSION 4 FILED
Tuesday, October 3, 2017TEAS EXTENSION RECEIVED
Thursday, March 30, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 29, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 29, 2017EXTENSION 3 GRANTED
Wednesday, March 22, 2017EXTENSION 3 FILED
Wednesday, March 22, 2017TEAS EXTENSION RECEIVED
Monday, January 30, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 25, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 24, 2016EXTENSION 2 GRANTED
Monday, October 10, 2016EXTENSION 2 FILED
Monday, October 10, 2016TEAS EXTENSION RECEIVED
Tuesday, May 17, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 16, 2016EXTENSION 1 GRANTED
Friday, April 8, 2016EXTENSION 1 FILED
Wednesday, May 11, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 8, 2016TEAS EXTENSION RECEIVED
Tuesday, October 13, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 18, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 18, 2015PUBLISHED FOR OPPOSITION
Wednesday, July 29, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 16, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 8, 2015ASSIGNED TO LIE
Tuesday, June 23, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 18, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 17, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 17, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 1, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 1, 2015NON-FINAL ACTION E-MAILED
Monday, June 1, 2015NON-FINAL ACTION WRITTEN
Friday, May 29, 2015ASSIGNED TO EXAMINER
Monday, March 9, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 26, 2015NEW APPLICATION ENTERED IN TRAM